Winning Health Technology disclosed its 2026 interim report, with operating revenue of 994 million yuan for the period, up 18.50 percent year on year, but net loss attributable to shareholders of the parent company was 176 million yuan, wider than the 118 million yuan loss in the same period last year. The weaker performance was mainly due to large impairment losses on contract assets and accounts receivable totaling more than 117 million yuan, while higher research and development and sales spending and investment losses from associates also dragged on profit. By product, software and services revenue was 828 million yuan, up 16.55 percent year on year; systems integration revenue was 67.35 million yuan, a slight increase of 1.73 percent; and internet healthcare revenue was 99.15 million yuan, surging 58.32 percent as a bright spot, though the low-margin integration business weighed on the overall structure. Selling expenses were 153 million yuan, up 26.03 percent year on year; administrative expenses were 115 million yuan, up 43.32 percent; and research and development expenses were 172 million yuan, up 38.71 percent, with higher staff pay the main reason. Among shareholders, director Jin Mao reduced holdings by 1.2236 million shares, and chief financial officer Wang Li reduced holdings by 282,500 shares, while actual controllers Zhou Wei and Wang Ying kept their holdings unchanged. Zhou Wei was previously sentenced for the crime of unit bribery, and the company and Zhou Wei received warning letters and public reprimands. The credit rating of the company and its convertible bonds remains AA, but the rating outlook has been revised to negative.
Shanghai Kingstar Winning SoftwareCompany reported a wider net loss of 176 million yuan due to impairments and higher expenses, with rating outlook revised to negative.
